European equities are drawing cautiously constructive research attention, with the DAX set up for near-term gains and European banks winning meaningful medium-term conviction — while legacy carmakers face a structural squeeze.
Researchers point to positive pre-market signals and an upcoming DAX earnings season as immediate catalysts, with one view arguing the index could test record highs at today's open. A broader published case for European bank stocks rests on forward valuations below US peers, stronger capital, cleaner loan books, and structural tailwinds — domestic growth initiatives, AI-driven efficiency gains, and the prospect of cross-border consolidation — that analysts argue support a re-rating over the next 12 months. A parallel strand of research adds that Germany's aggressive fiscal push and Europe's drive for supply-chain sovereignty reinforce the multi-year bull case for the sector.
On the bearish side, a contrarian thread argues Europe's legacy automakers are structurally losing share to Chinese EV brands, with names like Fiat and Citroën already retreating from key markets and no policy backstop in view.
Separately, some recently-published views flag Novo Nordisk as a standout, citing record GLP-1 sales momentum extending into new therapeutic areas.